hkr.sePublikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Manganese inhibits viability of prostate cancer cells
Högskolan Kristianstad, Forskningsmiljön Man & Biosphere Health (MABH). Högskolan Kristianstad, Sektionen för lärande och miljö, Avdelningen för Naturvetenskap. The Royal Swedish Academy of Sciences.ORCID-id: 0000-0002-4102-2885
Högskolan Kristianstad, Sektionen för lärande och miljö, Avdelningen för Naturvetenskap. Högskolan Kristianstad, Forskningsmiljön Man & Biosphere Health (MABH).
University of Gothenburg.
Högskolan Kristianstad, Sektionen för lärande och miljö, Avdelningen för Naturvetenskap. Högskolan Kristianstad, Forskningsmiljön Man & Biosphere Health (MABH).
2018 (engelsk)Inngår i: Anticancer Research, ISSN 0250-7005, E-ISSN 1791-7530, Vol. 38, nr 1, s. 137-145Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

BACKGROUND/AIM: Androgen deprivation therapy is usually in the initial phase a successful treatment for prostate cancer but eventually most patients develop androgen-independent metastatic disease. This study investigated if manganese (Mn) reduces viability of prostate cancer via induction of apoptosis.

MATERIALS AND METHODS: The prostate cancer cell lines PC3, DU145 and LNCaP underwent dose- and time-dependent screening of viability, analyzed by the 3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyl-tetrazolium bromide assay. Flow cytometry was used for the cell-cycle and apoptosis analyses. Intracellular Mn concentration was measured using inductively coupled plasma-mass spectrometry.

RESULTS: At Mn concentrations of 200-1000 μM, the effect on viability was most pronounced in PC3 followed by LNCaP cells. These cell lines also showed higher intracellular concentration of Mn compared to DU145. In all cell lines, Mn increased the proportion of cells arrested in the G0/G1 phase and induced apoptosis.

CONCLUSION: To our knowledge, this is the first report demonstrating Mn as a potential agent in prostate cancer therapy.

sted, utgiver, år, opplag, sider
2018. Vol. 38, nr 1, s. 137-145
Emneord [en]
DU145, LNCaP, Manganese, PC3, apoptosis, cell viability, prostate cancer
HSV kategori
Identifikatorer
URN: urn:nbn:se:hkr:diva-17770DOI: 10.21873/anticanres.12201ISI: 000419130100018PubMedID: 29277766OAI: oai:DiVA.org:hkr-17770DiVA, id: diva2:1171763
Tilgjengelig fra: 2018-01-08 Laget: 2018-01-08 Sist oppdatert: 2018-01-18bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekstPubMed

Personposter BETA

Tassidis, Helena

Søk i DiVA

Av forfatter/redaktør
Hernroth, BodilHolm, IngvarTassidis, Helena
Av organisasjonen
I samme tidsskrift
Anticancer Research

Søk utenfor DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 59 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf